Yasuyo Morita Selected Research

juzentaihoto

1/2021	Juzentaihoto Suppresses Muscle Atrophy and Decreased Motor Function in SAMP8 Mice.
1/2019	Juzentaihoto Suppresses Muscle Atrophy in Streptozotocin-Induced Diabetic Mice.
1/2019	Juzentaihoto hot water extract alleviates muscle atrophy and improves motor function in streptozotocin-induced diabetic oxidative stress mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuyo Morita Research Topics

Disease

4	Chronic Hepatitis C 01/2016 - 01/2002
3	Delirium 01/2022 - 01/2020
3	Muscular Atrophy (Muscle Atrophy) 01/2021 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 10/2020 - 09/2005
2	Dementia (Dementias) 01/2022 - 01/2020
2	Inflammation (Inflammations) 10/2021 - 09/2006
2	Infections 10/2021 - 03/2010
2	Hypoglycemia (Reactive Hypoglycemia) 10/2020 - 10/2020
2	Fibrosis (Cirrhosis) 03/2010 - 09/2006
1	Empyema 10/2021
1	Atrophy 01/2021
1	Heart Failure 01/2021
1	Sarcopenia 01/2021
1	Constipation 10/2020
1	Diarrhea 10/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Chemotherapy-Induced Febrile Neutropenia 02/2020
1	Breast Neoplasms (Breast Cancer) 02/2020
1	Febrile Neutropenia 02/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Muscle Weakness 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Hypokalemia 01/2020
1	Liddle Syndrome 01/2020
1	Alcoholic Fatty Liver 04/2012
1	Mental Disorders (Mental Disorder) 01/2012
1	Hepatitis C 03/2010
1	Diabetes Mellitus 03/2010
1	Hepatocellular Carcinoma (Hepatoma) 03/2010
1	Substance-Related Disorders (Drug Abuse) 09/2006
1	Autoimmune Diseases (Autoimmune Disease) 09/2006
1	Non-alcoholic Fatty Liver Disease 09/2005
1	Pathologic Complete Response 06/2003

Drug/Important Bio-Agent (IBA)

3	juzentaihotoIBA 01/2021 - 01/2019
3	Insulin (Novolin)FDA Link 01/2021 - 09/2005
2	Yi-Gan SanIBA 01/2022 - 01/2020
2	UbiquitinIBA 01/2021 - 01/2019
2	Febuxostat FDA Link 10/2020 - 10/2020
2	repaglinide (Prandin)FDA Link 10/2020 - 10/2020
2	nilotinib FDA Link 10/2020 - 10/2020
2	Pharmaceutical PreparationsIBA 10/2020 - 01/2020
2	Hormones (Hormone)IBA 02/2020 - 03/2010
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2019
2	Ribavirin (Virazole)FDA LinkGeneric 01/2012 - 06/2010
2	InterferonsIBA 01/2012 - 01/2002
2	Blood Glucose (Blood Sugar)IBA 09/2006 - 09/2005
1	Daptomycin FDA Link 10/2021
1	Anti-Infective Agents (Microbicides)IBA 10/2021
1	Linezolid (Zyvox)FDA Link 10/2021
1	Ligases (Synthetase)IBA 01/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	CytokinesIBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	SecretagoguesIBA 10/2020
1	Lubiprostone FDA Link 10/2020
1	AlkaloidsIBA 10/2020
1	Opioid Analgesics (Opioids)IBA 10/2020
1	Vinca AlkaloidsIBA 10/2020
1	Chloride Channels (Chloride Channel)IBA 10/2020
1	LaxativesIBA 10/2020
1	Short-Acting InsulinIBA 10/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2020
1	Estrogen ReceptorsIBA 02/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2020
1	Docetaxel (Taxotere)FDA Link 02/2020
1	ErbB Receptors (EGF Receptor)IBA 02/2020
1	Epirubicin (Ellence)FDA LinkGeneric 02/2020
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	daclatasvirIBA 01/2016
1	asunaprevirIBA 01/2016
1	ferric oxide (iron oxide)IBA 04/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2010
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2006
1	Biomarkers (Surrogate Marker)IBA 09/2006
1	Peptides (Polypeptides)IBA 09/2006
1	IronIBA 09/2006
1	Hyaluronic Acid (Hyaluronan)IBA 09/2006
1	LeptinIBA 09/2006
1	Triglycerides (Triacylglycerol)IBA 09/2006
1	Collagen Type III (Type III Collagen)IBA 09/2006
1	Collagen Type IV (Type IV Collagen)IBA 09/2006
1	AntibodiesIBA 09/2006
1	Nateglinide (Starlix)FDA LinkGeneric 09/2005
1	Alanine Transaminase (SGPT)IBA 06/2003
1	Interferon-alpha (Interferon Alfa)IBA 01/2002
1	Interferon-gamma (Interferon, gamma)IBA 01/2002

Therapy/Procedure

3	Therapeutics 01/2019 - 03/2010
2	Kampo Medicine (Kampo) 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 10/2020 - 02/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021
1	Exercise Therapy (Therapy, Exercise) 09/2005